Informação sobre produto
- N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[ (1-methylpiperidin-4-yl)methoxy]quinazolineZD 6474
- 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline
- 4-Quinazolinamine, N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-
- Azd-6474
- Azd6474
- Caprelsa
- Ch 331
- N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazolin-4-amine
- N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-(N-methylpiperidin-4-ylmethoxy)quinazolin-4-amine
- N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine
- Ver mais sinónimos
- N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine
- N-(4-bromo-2-fluoro-phenyl)-6-methoxy-7-[(1-methyl-4-piperidyl)methoxy]quinazolin-4-amine
- Vandetanib, Zactima, ZD6474
- Zactima
- Zd-6474
- Vandetanib
Vandetanib is antineoplastic kinase inhibitor that binds to the ATP-binding site of the enzyme squamous cell carcinoma kinase (SQSTM1). This binding inhibits the phosphorylation of the Bcl-2 protein and causes apoptosis. Vandetanib has been shown to have an effect on polymerase chain reaction amplification, terminal erythrocyte differentiation, and on gene expression in human tissue.
Vandetanib is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.
Propriedades químicas
Consulta técnica sobre: 3D-BV164508 Vandetanib - Bio-X ™
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.